About Alveron Pharma
Alveron Pharma is a company based in Nijmegen (Netherlands) founded in 2019.. Alveron Pharma has raised $11.79 million across 3 funding rounds from investors including Rijksdienst voor Ondernemend Nederland, Oost NL and Thuja Capital. Alveron Pharma offers products and services including OKL-1111. Alveron Pharma operates in a competitive market with competitors including Hemab, Basking Biosciences, Acticor Biotech, Varmx and Remedy Pharmaceuticals, among others.
- Headquarter Nijmegen, Netherlands
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$11.79 M (USD)
in 3 rounds
-
Latest Funding Round
$4.51 M (USD), Series A
Oct 07, 2021
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Alveron Pharma
Alveron Pharma offers a comprehensive portfolio of products and services, including OKL-1111. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Rapid treatment for haemorrhagic stroke to improve outcomes.
Unlock access to complete
Funding Insights of Alveron Pharma
Alveron Pharma has successfully raised a total of $11.79M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $4.51 million completed in October 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $4.5M
-
First Round
First Round
(16 May 2019)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2021 | Amount | Debt – Conventional - Alveron Pharma | Valuation |
investors |
|
| Oct, 2021 | Amount | Series A - Alveron Pharma | Valuation | Thuja Capital , Waterman Ventures |
|
| May, 2019 | Amount | Series A - Alveron Pharma | Valuation | Thuja Capital , Oost NL |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Alveron Pharma
Alveron Pharma has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Rijksdienst voor Ondernemend Nederland, Oost NL and Thuja Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage centric life sciences focused VC firm funding in Netherlands, Belgium and the US
|
Founded Year | Domain | Location | |
|
Waterman Ventures is focused on supporting innovative growing businesses.
|
Founded Year | Domain | Location | |
|
Sector-agnostic VC firm investing in geographies such as the Netherlands
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Alveron Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Alveron Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Alveron Pharma Comparisons
Competitors of Alveron Pharma
Alveron Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hemab, Basking Biosciences, Acticor Biotech, Varmx and Remedy Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Preventative therapies for rare bleeding and thrombotic disorders are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for ischemic stroke treatment are developed.
|
|
| domain | founded_year | HQ Location |
Immunotherapeutics are developed for ischemic stroke treatment using monoclonal antibodies.
|
|
| domain | founded_year | HQ Location |
Therapeutic proteins are developed to restore blood clotting in patients.
|
|
| domain | founded_year | HQ Location |
Intravenous formulation for acute central nervous system conditions such as stroke (ischemic and hemorrhagic), traumatic brain injury.
|
|
| domain | founded_year | HQ Location |
Oral iron chelators are developed for iron overload disease treatment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Alveron Pharma
Frequently Asked Questions about Alveron Pharma
When was Alveron Pharma founded?
Alveron Pharma was founded in 2019.
Where is Alveron Pharma located?
Alveron Pharma is headquartered in Nijmegen, Netherlands. It is registered at Nijmegen, Gelderland, Netherlands.
Is Alveron Pharma a funded company?
Alveron Pharma is a funded company, having raised a total of $11.79M across 3 funding rounds to date. The company's 1st funding round was a Series A of $7.28M, raised on May 16, 2019.
What does Alveron Pharma do?
Alveron Pharma was founded in 2019 and is based in Nijmegen, Netherlands. Operations are centered in the pharmaceutical sector, where treatments for haemorrhagic stroke and intracranial haemorrhage are developed. Emphasis is placed on OKL-1111, a drug advanced as a rapid first-line therapy for intracranial hemorrhage. Research and development efforts are conducted to address these neurological conditions.
Who are the top competitors of Alveron Pharma?
Alveron Pharma's top competitors include Acticor Biotech, Varmx and Remedy Pharmaceuticals.
What products or services does Alveron Pharma offer?
Alveron Pharma offers OKL-1111.
Who are Alveron Pharma's investors?
Alveron Pharma has 4 investors. Key investors include Rijksdienst voor Ondernemend Nederland, Oost NL, Thuja Capital, and Waterman Ventures.